TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
226,197
|
215,338
|
187,359 |
| Financial expenses |
2,223
|
11
|
1,074 |
| Earnings before taxes |
8,852
|
16,262
|
7,583 |
| EBITDA |
26,345
|
34,447
|
28,044 |
| Total assets |
241,884
|
164,751
|
126,621 |
| Current assets |
120,236
|
59,900
|
39,986 |
| Current liabilities |
39,326
|
34,196
|
32,278 |
| Equity capital |
103,402
|
104,792
|
91,711 |
| - share capital |
2,176
|
2,253
|
2,247 |
| Employees (average) |
989
|
1,065
|
984 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
42.7%
|
63.6%
|
72.4% |
| Turnover per employee |
229
|
202
|
190 |
| Profit as a percentage of turnover |
3.9%
|
7.6%
|
4.0% |
| Return on assets (ROA) |
4.6%
|
9.9%
|
6.8% |
| Current ratio |
305.7%
|
175.2%
|
123.9% |
| Return on equity (ROE) |
8.6%
|
15.5%
|
8.3% |
| Change turnover |
18,180
|
27,434
|
26,679 |
| Change turnover % |
9%
|
15%
|
17% |
| Chg. No. of employees |
-76
|
81
|
102 |
| Chg. No. of employees % |
-7%
|
8%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.